SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-007260
Filing Date
2016-08-15
Accepted
2016-08-15 16:59:01
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-063016.htm 10-Q 291007
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 9932
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 9920
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 3630
  Complete submission text file 0001019687-16-007260.txt   1588659

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20160630.xml EX-101.INS 173599
6 XBRL SCHEMA FILE xbio-20160630.xsd EX-101.SCH 22822
7 XBRL CALCULATION FILE xbio-20160630_cal.xml EX-101.CAL 41334
8 XBRL DEFINITION FILE xbio-20160630_def.xml EX-101.DEF 58881
9 XBRL LABEL FILE xbio-20160630_lab.xml EX-101.LAB 156673
10 XBRL PRESENTATION FILE xbio-20160630_pre.xml EX-101.PRE 123058
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-178082 | Film No.: 161833626
SIC: 2834 Pharmaceutical Preparations